Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Liver physiology and pathology, MicroRNA in disease regulation, and Cholangiocarcinoma and Gallbladder Cancer Studies.
Cholangiocarcinoma 2026: status quo, unmet needs and priorities
The barriers to uptake of artificial intelligence in hepatology and how to overcome them
Emergence and spread of the SARS-CoV-2 omicron (BA.1) variant across Africa: an observational study
Enteronephrohepatic circulation of bile acids and therapeutic potential of systemic bile acid transporter inhibitors
A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer development
Deep learning can predict cardiovascular events from liver imaging
Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter Study
Ferroptosis in health and disease
Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON)
HBV shows different levels of adaptation to HLA class I-associated selection pressure correlating with markers of replication
Regulation of KIF23 by miR-107 controls replicative tumor cell fitness in mouse and human hepatocellular carcinoma
Body Composition in Cholangiocarcinoma Affects Immune Cell Populations in the Tumor and Normal Liver Parenchyma
Systematic assessment of COVID-19 host genetics using whole genome sequencing data
Detection of Bacterial Infections and Malaria among Blood Culture-Negative Samples of Hospitalized Febrile Patients from a Tertiary Hospital in Ethiopia
Sublethal necroptosis signaling promotes inflammation and liver cancer
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis
Regulation of STING activity in DNA sensing by ISG15 modification
Prediction of heart transplant rejection from routine pathology slides with self-supervised deep learning
Long-term exposure to air pollution and prevalent nonalcoholic fatty liver disease
Hepatocytes reprogram liver macrophages involving control of TGF-β activation, influencing liver regeneration and injury
Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC)
Differences in the Time Course of Recovery from Brain and Liver Dysfunction in Conventional Long-Term Treatment of Wilson Disease
Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma
Swarm learning for decentralized artificial intelligence in cancer histopathology
Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025
Interruption of bile acid uptake by hepatocytes after acetaminophen overdose ameliorates hepatotoxicity
Precision oncology for intrahepatic cholangiocarcinoma in clinical practice
Prediction of heart transplant rejection from routine pathology slides with self-supervised Deep Learning